They found that glioma cells can transfer extracellular vesicles (EVs) with the EGFRvIII (oncogenic receptor) to adjacent glioma cells that lack this receptor, therefore leading to activation of the AKT pathway in neighboring glioma cells. This evidence concerns the gene AKT1 and central nervous system cancer.